Model‐based dose finding under model uncertainty using general parametric models
Authors:
- 3 December 2013
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 33 (10) , 1646-1661
Abstract
The statistical methodology for the design and analysis of clinical Phase II dose‐response studies, with related software implementation, is well developed for the case of a normally distributed, homoscedastic response considered for a single timepoint in parallel group study designs. In practice, however, binary, count, or time‐to‐event endpoints are encountered, typically measured repeatedly over time and sometimes in more complex settings like crossover study designs. In this paper, we develop an overarching methodology to perform efficient multiple comparisons and modeling for dose finding, under uncertainty about the dose‐response shape, using general parametric models. The framework described here is quite broad and can be utilized in situations involving for example generalized nonlinear models, linear and nonlinear mixed effects models, Cox proportional hazards models, with the main restriction being that a univariate dose‐response relationship is modeled, that is, both dose and response correspond to univariate measurements. In addition to the core framework, we also develop a general purpose methodology to fit dose‐response data in a computationally and statistically efficient way. Several examples illustrate the breadth of applicability of the results. For the analyses, we developed theRadd‐on packageDoseFinding, which provides a convenient interface to the general approach adopted here. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Model-Based Bayesian Adaptive Dose-Finding Designs for a Phase II TrialStatistics in Biopharmaceutical Research, 2011
- Adaptive and Model-Based Dose-Ranging Trials: Quantitative Evaluation and Recommendations. White Paper of the PhRMA Working Group on Adaptive Dose-Ranging StudiesStatistics in Biopharmaceutical Research, 2010
- The impact of dropouts on the analysis of dose‐finding studies with recurrent event dataStatistics in Medicine, 2010
- Evaluating potential benefits of dose–exposure–response modeling for dose findingPharmaceutical Statistics, 2009
- Critical aspects of the Bayesian approach to phase I cancer trialsStatistics in Medicine, 2008
- Adaptive Designs for Dose-Finding Studies Based on SigmoidEmaxModelJournal of Biopharmaceutical Statistics, 2007
- Design and Analysis of Dose-Finding Studies Combining Multiple Comparisons and Modeling ProceduresJournal of Biopharmaceutical Statistics, 2006
- Analysis of Nonlinear Regression Models: A Cautionary NoteDose-Response, 2005
- Analyzing incomplete longitudinal clinical trial dataBiostatistics, 2004
- Nonlinearity of dose-response functions for carcinogenicity.Environmental Health Perspectives, 1994